News
Researchers discovered that S. haematobium infection can trigger changes in gene activity associated with cancer development in the cervical lining, and alarmingly, these changes intensify ...
could also trigger cancer-related gene activity in the cervical lining. Even more troubling, the genetic changes appear to intensify after treatment, a red flag that researchers say suggests ...
Cervical cancer rates are rising in women in their 30s and 40s — why, and what you can do about it
Cervical cancer rates are on the rise among younger women, owing in part to a lack of awareness, screening and prevention. A new study found that the percentage of women screened for cervical ...
Researchers at AIIMS, Delhi have developed a simple blood test using droplet digital PCR (ddPCR) to track the effectiveness of cervical cancer treatment. Published in Scientific Reports ...
A parasitic disease, already known to cause bladder cancer, may also influence cervical cancer risk.(Shutterstock) The research, shared at the ESCMID Global 2025 conference on April 12 ...
Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the Danish Cancer Society said on Monday. "Even before 2040, so few women may ...
Denmark is working towards eliminating cervical cancer by 2040. The Danish Cancer Society announced this initiative. A national HPV vaccination campaign and screening program are underway.
Launched in 2023 to prevent cervical cancer, India’s first indigenous human papilloma virus (HPV) vaccine—Cervavac—has found only 63 takers in the 18-25 age group at the Post Graduate ...
DIY smear tests for women are part of an NHS plan to eradicate cervical cancer by 2040. Outgoing NHS boss Amanda Pritchard has unveiled measures to achieve the “world-leading ambition ...
The research is published in the journal Scientific Reports. The team discovered a novel global cooperative phenomenon, a hidden causal interaction network, in monolayers of HeLa cervical cancer ...
The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) for advanced or recurrent cervical cancer that has progressed on or ...
She was speaking while receiving a delegation of the National Taskforce on Cervical Cancer Elimination led by the Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results